Skip to main content
Header logo
  • About Moberg Open link menu
    About Moberg
    • CEO Comments
    • Business Model
    • Board and Leadership
  • MOB-015
  • Sustainability
  • Investors Open link menu
    Investors
    • Results and Presentations
    • The share Open link menu
      The share
      • Major shareholders
      • Insider Trading
      • Financial Data
    • Analysts
    • Calendar
    • Corporate governance Open link menu
      Corporate governance
      • Board of directors
      • Management
      • General shareholders meetings
      • Nomination committee
      • Auditors
      • Remuneration
      • Share-based incentive program
      • Articles of Association
    • Press releases
    • Prospectus
  • Media Open link menu
    Media
    • Image Archive
    • Press Releases
  • Contact
    • EN Current language English, click to switch language
    • SV Switch to Swedish
  • Please fill out this field
Close
Please fill out this field
Press Releases
Breadcrumbs
  • Home
  • Media
  • Press Releases

Press Releases

Press Releases Regulatory Press Releases
More
Press Releases Data
2017-09-01 08:00
Phase 2-results for BUPI published
Read more
2017-08-28 08:30
Moberg Pharma completes divestment of Fiber Choice for $6.7 million
Read more
2017-08-21 08:00
Moberg Pharma divests Fiber Choice for $6.7 million
Read more
2017-08-08 18:30
Minor correction of the Interim report for January - June 2017
Read more
2017-08-08 08:00
Interim report January - June 2017
Read more
2017-08-07 08:30
Successful results from the clinical trial for Kerasal Nail/Emtrix
Read more

Pagination

  • First page
  • Previous page
  • …
  • Page 38
  • Page 39
  • Page 40
  • Page 41
  • Current page 42
  • Page 43
  • Page 44
  • Page 45
  • Page 46
  • …
  • Next page
  • Last page
Press Releases Data
2016-01-21 08:00
Moberg Pharma is contemplating a potential bond issue and updates financial targets
Read more
2016-01-11 08:30
Moberg Pharma announces positive phase II data for BUPI
Read more
2016-01-08 08:30
Change in Moberg Pharma's nomination committee
Read more
2015-12-30 08:30
Change in number of shares and votes in Moberg Pharma
Read more
2015-12-22 08:30
Moberg Pharma expects to announce phase II data for BUPI in January
Read more
2015-11-17 08:30
Moberg Pharma's Nomination Committee appointed
Read more

Pagination

  • First page
  • Previous page
  • …
  • Page 38
  • Page 39
  • Page 40
  • Page 41
  • Current page 42
  • Page 43
  • Page 44
  • Page 45
  • Page 46
  • …
  • Next page
  • Last page
What we do

Moberg Pharma AB
Telephone: 08-522 307 00
Email: [email protected]

Mailing Address: 
Gustavslundsvägen 42, 167 51 Bromma
Visiting Address: 
Gustavslundsvägen 50, 167 51 Bromma

Sign up to receive our press releases and reports.

Sign up

Home
Moberg Pharma´s Interim report January - September 2024

Footer

  • Sitemap
  • Privacy Policy
  • Terms of Use
  • Cookies
  • Copyright
  • Cookie settings
  • © Moberg Pharma AB (publ) 2026